A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
暂无分享,去创建一个
P. Mclaughlin | R. Orlowski | C. Bueso-Ramos | L. Kwak | L. Fayad | S. Vadhan-Raj | M. Fanale | F. Hagemeister | B. Pro | N. Sarlis | J. Romaguera | A. Younes | N. Fowler | Jordi Cortés | A. Rodríguez | M. Wang | J. Shah | A. Rodriguez | X. Zhou | F. Samaniego | A. Rodríguez